Trial
NCT00574834
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer
Condition
Metabolic Syndrome
Intervention
Ramipril
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-12